A share price of Gilead Sciences, Inc [GILD] is currently trading at $129.11, up 4.00%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GILD shares have gain 6.04% over the last week, with a monthly amount glided 6.29%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On November 13, 2025, Scotiabank initiated with a Sector Outperform rating and assigned a price target of $140 on the stock. Daiwa Securities upgraded its rating to a Outperform but stick to its price target of $128 on August 19, 2025. Truist upgraded its rating to a Buy but $127 remained the price target by the analyst firm on August 08, 2025. Needham upgraded its rating to Buy for this stock on July 25, 2025, but kept the price target unchanged to $133.
Gilead Sciences, Inc experienced fluctuations in its stock price throughout the past year between $91.84 and $128.70. Currently, Wall Street analysts expect the stock to reach $135.08 within the next 12 months. Gilead Sciences, Inc [NASDAQ: GILD] shares were valued at $129.11 at the most recent close of the market. An investor can expect a potential return of 4.62% based on the average GILD price forecast.
Analyzing the GILD fundamentals
Trailing Twelve Months sales for Gilead Sciences, Inc [NASDAQ:GILD] were 29.05B which represents 3.36% growth. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at 0.36%, Pretax Profit Margin comes in at 0.34%, and Net Profit Margin reading is 0.28%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.41 and Total Capital is 0.23. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Gilead Sciences, Inc [NASDAQ:GILD] is 1.45. Also, the Quick Ratio is 1.31, while the Cash Ratio stands at 0.6. Considering the valuation of this stock, the price to sales ratio is 5.51, the price to book ratio is 7.44 and price to earnings (TTM) ratio is 20.00.
Transactions by insiders
Recent insider trading involved Bluestone Jeffrey, Director, that happened on Jan 20 ’26 when 5000.0 shares were sold. Director, JEFFREY BLUESTONE completed a deal on Jan 20 ’26 to buy 5000.0 shares. Meanwhile, Chief Financial Officer Dickinson Andrew D sold 3000.0 shares on Jan 15 ’26.
